Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01349 FUDANZHANGJIANG
RTNominal unchange3.990 0.000 (0.000%)
Result Announcements

30/04/2021 09:01

Fudan-Zhangjiang (01349) 1Q net turns profit at RMB5.12m

[ET Net News Agency, 30 April 2021] Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,
Ltd. (01349) said its net profit attributable to shareholders of the listed company was
RMB5.12 million for the first quarter of 2021, compared to the loss of RMB18.29 million of
the same period last year.
Revenue was RMB126.20 million, a year-on-year increase of 263.52%. (RC)

Remark: Real time quote last updated: 26/11/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.